Subscribe
shutterstock-135807482-roche-1
lucarista / shutterstock.com
13 July 2021MedtechAlex Baldwin

English court says Roche did not infringe insulin pump patents

The  English High Court has cleared  Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.


Editor's picks

Latham steps into dispute over $6bn treatment, replacing Kirkland
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025

Editor's picks

Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
Roche and Bluebird settle ‘Spark’ TM suit
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Big Pharma
Roche asks court for halt of Novartis unit’s generic launch
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

More features

Weil adds two more litigators from larger rival
Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Latham steps into dispute over $6bn treatment, replacing Kirkland
Patent pollution: Emissions charter aims to clean up IP
Harvard’s patent portfolio at risk as Trump turns up the pressure
Weil adds leaders from Latham to head up tech and life sciences
$740M deal ends COVID-19 vaccine feud between CureVac and BioNTech
CyDex trade secrets case tossed by Italian court in rare ruling